) [153]. This process is at this time not scalable mainly because it relies on high priced startup substrates which may be made use of to produce psilocybin in cheaper chemical synthesis methodologies. A methodology for de novo creation of psilocybin and tryptamine derivatives in Saccharomyces cerevisiae,We provide individualized mental health proc